Mursla is dedicating resources to help improve covid-19 diagnostics & therapeutics solutions.
We are currently capitalising upon our expertise in exosome-based medical applications & nanobiotech technologies to help on:
- Diagnostics: Develop a novel isolation and detection tool of SARS-CoV-2 virion, which is very similar in size & structure as exosome.
- Therapeutics: Coordinate a consortium focused on developing stem cell-derived exosome therapy for Covid-19 hospitalized patients exhibiting life-threatening Acute Respiratory Distress Syndrome (ARDS) and/or for Covid-19 recovered patients suffering from heavily impaired lungs.
We are disseminating less-known tech & bio facts on the situation (e.g. diagnostics tools, link between exosomes & viruses) via academic publications and social media.
We hope to be as helpful as possible to our community during those difficult times.